New application of glucagon receptor allosteric antagonist Aduglibane
By using the allosteric antagonist of glucagon receptor Aduglifan to prepare anti-rice blast bacteria drugs, the problem of weakening the effects of traditional agents is solved, effective inhibition of rice blast bacteria is achieved, and high efficiency and low efficiency are provided. The poisonous rice blast prevention and control plan has enhanced the healthy growth and food security of rice.
Patent Information
- Application Number
- CN202410843262.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-06-27
- Publication Date
- 2024-11-08
AI Technical Summary
The effect of traditional rice blast agents has gradually weakened, resulting in increased difficulty in prevention and treatment, affecting rice yield and quality, and having adverse effects on the ecosystem, lacking new drugs with high efficiency, low toxicity and environmentally friendly.
Adomeglivant, the allosteric antagonist of glucagon receptor, was used to prepare antifungal drugs, especially against rice blast bacteria, by inhibiting its growth, spore production, pathogenicity and conidia germination. Attachment cells form.
Aduglifan showed good antibacterial activity, significantly inhibiting the pathogenicity of rice blast bacteria, providing new methods of rice blast prevention and control, reducing production costs, and reducing the impact on the ecosystem.
Smart Images

Figure CN118901711A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of rice blast prevention and control, and specifically relates to a new use of a glucagon receptor allosteric antagonist, aduglifan. Background Art
[0002] Controlling rice blast is extremely important for ensuring global food security, maintaining stable agricultural production and increasing farmers' income. As a major threat to rice production, rice blast can seriously reduce rice yield and quality, affect food supply, and thus affect every link in the food chain. Through scientific management measures, the application of disease-resistant varieties and reasonable chemical control, the negative impact of rice blast can be greatly reduced, ensuring the healthy development of the rice planting industry and providing a stable food source for the growing world population.
[0003] Exploring new agents for the prevention and treatment of rice blast is an urgent need to meet the continuous challenges of this stubborn disease. With the continuous evolution and increased resistance of rice blast fungi, the effectiveness of traditional agents has gradually weakened, making prevention and control more difficult, seriously affecting the yield and quality of rice. Therefore, the development of new, efficient, low-toxic and environmentally friendly agents has become the key to ensuring food security. This can not only provide agricultural production with more powerful tools to deal with sudden or persistent outbreaks of rice blast, but also reduce the adverse effects on the ecosystem, which is in line with the concept of green development of modern agriculture. The discovery and application of new agents will help achieve precise application of pesticides and reduce production costs, while promoting agricultural scientific and technological innovation and enhancing the resilience and sustainability of the global food system. In short, the continuous exploration and use of new agents for the prevention and control of rice blast is an important way to maintain the healthy growth of rice and ensure world food security.
[0004] Adomeglivant (LY2409021), Chinese name Adu Gelifan, CAS number: 1488363-78-5, is a highly selective glucagon receptor (GluR) allosteric antagonist. Its chemical structure is:
[0005]
[0006] Its main function is to block the increase in cAMP levels caused by glucagon in a dose-dependent manner, so the development and research of Adomeglivant are mainly focused on the field of type 2 diabetes. According to the available information, the main application of Adomeglivant is related to scientific research and medicine, especially in drug development and biochemical research. There are no reports or studies showing that Adomeglivant has antifungal effects and can be used to inhibit fungal infection. Summary of the invention
[0007] In view of the problems existing in the prior art, the purpose of the present invention is to design and provide a technical solution for the new use of the glucagon receptor allosteric antagonist arduglifan.
[0008] The present invention is specifically implemented by the following technical solutions:
[0009] The first aspect of the present invention provides the use of a glucagon receptor allosteric antagonist, ardugliflozin, in the preparation of an antifungal drug. The CAS number of the glucagon receptor allosteric antagonist, ardugliflozin, is 1488363-78-5.
[0010] Furthermore, the fungus in the application is rice blast fungus.
[0011] The second aspect of the present invention provides an antifungal drug, the active ingredient of which contains the glucagon receptor allosteric antagonist ardugliflozin.
[0012] Furthermore, the fungus in the anti-rice blast fungus drug is rice blast fungus.
[0013] Furthermore, the anti-rice blast fungus drug is in the form of an injection, tablet, pill, capsule, suspension, granule, spray or emulsion.
[0014] The third aspect of the present invention provides the use of the above-mentioned anti-rice blast fungus drug in preventing and controlling rice blast fungus infection.
[0015] The technical scheme of the present invention discloses a new medical use of the glucagon receptor allosteric antagonist aduglifan, which has good antibacterial activity against rice blast fungus, can inhibit the conidia germination and appressorium formation of rice blast fungus, and thus affect the pathogenicity. The glucagon receptor allosteric antagonist aduglifan has the prospect of being used to prevent and treat rice blast fungus infection, and provides a reference basis for the development of antibacterial drugs based on the lead structure of the glucagon receptor allosteric antagonist aduglifan. BRIEF DESCRIPTION OF THE DRAWINGS
[0016] Figure 1 Adomeglivant inhibits the growth and sporulation of rice blast fungus;
[0017] Figure 2 Adomeglivant inhibits the pathogenicity of rice blast fungus;
[0018] Figure 3 Adomeglivant inhibits conidia germination and appressorium formation of rice blast fungus. DETAILED DESCRIPTION
[0019] The present invention is further described below with reference to the examples.
[0020] Example 1: Adomeglivant inhibits the growth and sporulation of rice blast fungus
[0021] The same size of rice blast fungus cake was inoculated on a complete medium plate containing different concentrations of Adomeglivant, specifically 0, 10, 20 and 50 μM. The plate was placed in an incubator at 25°C and cultured under alternating light and dark conditions for 6 days. The colony diameter and the number of conidia were counted. Each treatment was repeated three times. The diameter measurement results and the plate conidia statistics showed that ( Figure 1 As shown in the figure, with the increase of Adomeglivant concentration in the plate, the growth of rice blast fungus was significantly inhibited, and the growth inhibition rate gradually increased. Adomeglivant at a concentration of 10 μM induced an increase in spore production, and as the concentration increased, spore production decreased. This result suggests that Adomeglivant has a concentration-dependent characteristic in inhibiting the growth and spore production of rice blast fungus.
[0022] Example 2: Adomeglivant inhibits the pathogenicity of rice blast fungus
[0023] The rice blast fungus strain was cultured in a 25°C incubator under alternating dark / light conditions for 6 days. The colonies were washed with sterile water, the conidia on the plates were collected, and the spore solution concentration was adjusted to 1×10 6 / mL, different volumes of Adomeglivant were mixed with conidia of rice blast fungus and then sprayed on four-week-old rice seedlings of rice blast susceptible variety CO39. The spores of rice blast fungus with DMSO added were used as a control. After inoculation, the mixture was first treated at 22°C in the dark for 2 days, and then cultured at 25°C in alternating light / dark conditions for 5 days. After 7 days, photos were taken and the leaf spot area was counted using Photoshop software. The results showed that (such as Figure 2 As shown in Figure 2, yellow and brown lesions appeared on the leaves of the control group. However, the lesion area of the experimental group under the condition of 10 μM Adomeglivant was significantly smaller. These results show that Adomeglivant has a significant inhibitory effect on the pathogenicity of rice blast fungus.
[0024] Example 3: Adomeglivant inhibits conidia germination and appressorium formation of Magnaporthe oryzae
[0025] We further analyzed the reasons why Adomeglivant inhibited the pathogenicity of rice blast fungus through microscopic observation. The conidia of rice blast fungus were collected from the plates where rice blast fungus was cultured for 7 days, and the conidia concentration was measured by hemocytometer. The conidia concentration was adjusted to 1×10 5Adomeglivant was added to the conidia of rice blast fungus at a final concentration of 10 μM, and the same volume of DMSO was added as a control. The conidia were dropped on the surface of a hydrophobic glass slide and incubated in a dark and moisturizing environment at 25°C. After 4 hours, the germination of conidia was counted under a microscope, and the formation rate of conidial appressorium was counted after 24 hours. The results showed (eg Figure 3 After 4 hours of incubation, the conidia germination rate of Adomeglivant-treated cells was significantly lower than that of the control, and after 24 hours, the molecular spore appressorium formation rate of Adomeglivant-treated cells was significantly lower than that of the control. These results indicate that Adomeglivant affects the pathogenicity of rice blast fungus by inhibiting the germination of conidia and the formation of appressorium.
Claims
1. Use of a glucagon receptor allosteric antagonist, ardugliflozin, in the preparation of an antifungal drug, wherein the CAS number of the glucagon receptor allosteric antagonist, ardugliflozin, is: 1488363-78-5.
2. The use according to claim 1, characterized in that The fungus is rice blast fungus.
3. An antifungal drug, characterized in that: The active ingredient of this drug contains the glucagon receptor allosteric antagonist adugliflozin.
4. The anti-rice blast fungus drug according to claim 1, characterized in that: The fungus is rice blast fungus.
5. The anti-rice blast fungus drug according to claim 1, characterized in that: The medicine is in the form of injection, tablet, pill, capsule, suspension, granule, spray or emulsion.
6. Use of an anti-particle blast fungus drug as claimed in claim 3, 4 or 5 in preventing and controlling rice blast fungus infection.
